Combined chemotherapy and allogeneic human Vγ9Vδ2 T lymphocyte-immunotherapies efficiently control the development of human epithelial ovarian cancer cells in vivo

Epithelial ovarian cancer (EOC) represents 5% of human gynecologic cancers in the world, is heterogeneous and highly invasive with a dismal prognosis (5 year-survival rate <35%). Diagnosis of EOC is frequently made at advanced stages and, despite aggressive treatments combining surgery and chemot...

Descripción completa

Detalles Bibliográficos
Autores principales: Joalland, Noémie, Lafrance, Laura, Oullier, Thibauld, Marionneau-Lambot, Séverine, Loussouarn, Delphine, Jarry, Ulrich, Scotet, Emmanuel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2019
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6791416/
https://www.ncbi.nlm.nih.gov/pubmed/31646097
http://dx.doi.org/10.1080/2162402X.2019.1649971

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6791416/
https://www.ncbi.nlm.nih.gov/pubmed/31646097
http://dx.doi.org/10.1080/2162402X.2019.1649971

Ejemplares similares